These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


305 related items for PubMed ID: 25612463

  • 1. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.
    Aygun B, Mortier NA, Kesler K, Lockhart A, Schultz WH, Cohen AR, Alvarez O, Rogers ZR, Kwiatkowski JL, Miller ST, Sylvestre P, Iyer R, Lane PA, Ware RE, Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) Trial Investigators.
    Br J Haematol; 2015 Apr; 169(2):262-6. PubMed ID: 25612463
    [Abstract] [Full Text] [Related]

  • 2. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A, Ware RE, Thornburg CD.
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [Abstract] [Full Text] [Related]

  • 3. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
    Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH.
    J Pediatr; 2004 Sep; 145(3):346-52. PubMed ID: 15343189
    [Abstract] [Full Text] [Related]

  • 4. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.
    Wood JC, Cohen AR, Pressel SL, Aygun B, Imran H, Luchtman-Jones L, Thompson AA, Fuh B, Schultz WH, Davis BR, Ware RE, TWiTCH Investigators.
    Br J Haematol; 2016 Jan; 172(1):122-30. PubMed ID: 26523836
    [Abstract] [Full Text] [Related]

  • 5. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.
    Ware RE, Schultz WH, Yovetich N, Mortier NA, Alvarez O, Hilliard L, Iyer RV, Miller ST, Rogers ZR, Scott JP, Waclawiw M, Helms RW.
    Pediatr Blood Cancer; 2011 Dec 01; 57(6):1011-7. PubMed ID: 21826782
    [Abstract] [Full Text] [Related]

  • 6. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL, Cohen AR, Garro J, Alvarez O, Nagasubramanian R, Sarnaik S, Thompson A, Woods GM, Schultz W, Mortier N, Lane P, Mueller B, Yovetich N, Ware RE, SWiTCH Study Investigators.
    Am J Hematol; 2012 Feb 01; 87(2):221-3. PubMed ID: 22120913
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
    Alvarez O, Yovetich NA, Scott JP, Owen W, Miller ST, Schultz W, Lockhart A, Aygun B, Flanagan J, Bonner M, Mueller BU, Ware RE, Investigators of the Stroke With Transfusions Changing to Hydroxyurea Clinical Trial (SWiTCH).
    Am J Hematol; 2013 Nov 01; 88(11):932-8. PubMed ID: 23861242
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
    Franchini M, Gandini G, Veneri D, de Matteis G, Federici F, Solero P, Aprili G.
    Transfusion; 2004 Jun 01; 44(6):833-7. PubMed ID: 15157247
    [Abstract] [Full Text] [Related]

  • 10. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
    Majhail NS, Lazarus HM, Burns LJ.
    Biol Blood Marrow Transplant; 2010 Jun 01; 16(6):832-7. PubMed ID: 20079863
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM, Friedman DF, Webb J, Kwiatkowski JL.
    Pediatr Blood Cancer; 2016 Aug 01; 63(8):1414-8. PubMed ID: 27100139
    [Abstract] [Full Text] [Related]

  • 13. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA, Nzouakou R, Ameen V, Sirigireddy B, Amos RJ.
    Eur J Haematol; 2014 Feb 01; 92(2):164-7. PubMed ID: 24175986
    [Abstract] [Full Text] [Related]

  • 14. Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network.
    Tsouana E, Kaya B, Gadong N, Hemmaway C, Newell H, Simmons A, Whitmarsh S, Telfer P.
    Eur J Haematol; 2015 Apr 01; 94(4):336-42. PubMed ID: 25138173
    [Abstract] [Full Text] [Related]

  • 15. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
    Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC.
    Pediatr Blood Cancer; 2008 Feb 01; 50(2):319-24. PubMed ID: 17557314
    [Abstract] [Full Text] [Related]

  • 16. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA, Adly AA, Ismail EA, Darwish YW, Ali Zedan M.
    Blood Cells Mol Dis; 2014 Dec 01; 53(4):189-93. PubMed ID: 25065856
    [Abstract] [Full Text] [Related]

  • 17. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, Walker T, Nowicki MJ.
    J Pediatr Hematol Oncol; 2009 May 01; 31(5):309-12. PubMed ID: 19415007
    [Abstract] [Full Text] [Related]

  • 18. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Wilson SR, Sears M, Williams E, Drapekin J, Sivakumar I, Padrino S, Desai PC, Hager W, Manwani D, Clay LJ, Field JJ, Kanter J, Cohen AJ, Saif Ur Rehman S, Lanzkron S, Little JA, GRNDaD investigators.
    Br J Haematol; 2021 Dec 01; 195(5):e157-e160. PubMed ID: 34423416
    [No Abstract] [Full Text] [Related]

  • 19. The pathophysiology of transfusional iron overload.
    Porter JB, Garbowski M.
    Hematol Oncol Clin North Am; 2014 Aug 01; 28(4):683-701, vi. PubMed ID: 25064708
    [Abstract] [Full Text] [Related]

  • 20. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R, Belakhal F, Ben Salah N, Gouider E, Elborgi W.
    Tunis Med; 2011 Jun 01; 89(6):548-52. PubMed ID: 21681718
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.